Frederick G. Welt,
MD
Vice Chair of Clinical Affairs, Department of Internal Medicine
Languages Spoken: English
Frederick Welt, M.D. is Associate Chief of Cardiovascular Medicine at the University of Utah School of Medicine and Director of the Cardiac Catheterization Laboratory. He is a professor of medicine and member of the Interventional Cardiology faculty.
Dr. Welt most recently served as the Director of Interventional Cardiology at Brigham and Women's Hospital in Boston, as well as Director of the Interventional Cardiovascular Experimental Laboratory. His clinical practice included outpatient clinical care and performing diagnostic catheterizations and coronary interventions.
Dr. Welt specializes in both interventional coronary and structural heart disease cases including Trans Catheter Aortic Valve Replacement (TAVR). His clinical responsibilities include invasive management of acute heart attacks and assessment of valvular heart disease, coronary stent implantation/balloon angioplasty and PFO/ASD closure.
He is also an active clinical investigator, having been involved in the PARTNER trial of transcatheter aortic valve replacement devices, translational research of novel devices to treat structural heart disease and protocols involving stem cell therapy for cardiac disease.
Dr. Welt graduated from the Yale University School of Medicine in 1992, and completed residency and fellowship at the Brigham and Women's Hospital in Boston. He also served as Chief Resident at the West Roxbury VA Hospital and completed a research fellowship at Harvard Medical School. In addition to practicing and teaching at BWH and Harvard he has written numerous journal articles as well as serving as a reviewer for publications.
Clinical Locations
Basin Clinic
801-585-7676
Fax: (801) 581-7735
Evanston Regional Hospital
Cardiovascular Outreach Care801-585-7676
Fax: (801) 581-7735
Cardiovascular Center
801-585-7676
Fax: (801) 581-7735
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Professor (Clinical) |
| Academic Divisions | Cardiovascular Medicine |
| Board Certification | American Board of Internal Medicine (Sub: Cardiovascular Disease) American Board of Internal Medicine (Sub: Interventional Cardiology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.8/ 5
Care provider's explanation of condition/problem
4.7/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.5/ 5
Care provider's concern for questions & worries
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
November 09, 2021
UH HOSPITALS AND CLINICS
The doctor explained the procedure and how things may go.
UofU Patient
October 01, 2021
UH HOSPITALS AND CLINICS
While waiting in the exam room I heard the doctor say they were behind schedule so they had to be faster
UofU Patient
September 20, 2021
UH HOSPITALS AND CLINICS
Adjusting medication was good
UofU Patient
September 09, 2021
UH HOSPITALS AND CLINICS
Good.
UofU Patient
August 07, 2021
STANSBURY HEALTH CENTER
Good
UofU Patient
July 10, 2021
UH HOSPITALS AND CLINICS
I am grateful and blessed to have the U of U Medical as my service provider. The diagnosis is scary however, I feel knowledge is power and we have that moving forward. This is more than good. We have a team of professional doctors working for me/us. Thank you so much
UofU Patient
July 01, 2021
STANSBURY HEALTH CENTER
Dr. Welt was so kind and listened to all my concerns and took them seriously.
UofU Patient
June 24, 2021
UH HOSPITALS AND CLINICS
Dr. Welt is a very caring and helpful physician. He attends to all needs and is an outstanding physician.
UofU Patient
June 04, 2021
UH HOSPITALS AND CLINICS
dr welt is tops love him would never go anywhere elese
UofU Patient
March 05, 2021
UH HOSPITALS AND CLINICS
Dr Welt was great and explained the details of my heart very well. He listened to all my questions and answered them very patiently.
UofU Patient
December 08, 2020
EVANSTON REGIONAL HOSPITAL
Very caring and compassionate!
UofU Patient
October 26, 2020
UH HOSPITALS AND CLINICS
nurse practitioner very attentive and informative. doctor very caring, displayed empathy for my condition, focused only on me and not filling out his report, and displayed great expertise.
UofU Patient
October 05, 2020
UH HOSPITALS AND CLINICS
Good experience
UofU Patient
October 03, 2020
UH HOSPITALS AND CLINICS
Dr. Welt is the best cardiologist I've ever worked with!! He patiently explains his recommendations so I can understand.
UofU Patient
September 12, 2020
UH HOSPITALS AND CLINICS
Dr Welt was a very good listener and had my concerns in mind. Answered my questions and put me at ease.
UofU Patient
September 05, 2020
UH HOSPITALS AND CLINICS
Dr Welt projects a calming, reassuring presence, which was desirable this patient, who had been shocked by the original diagnosis (by a doctor not affiliated with UofU). He listened carefully, requested details, and thoughtfully considered our responses. His answers to our questions were specific and easily understood. He did not appear rushed or impatient, but very much concerned with our concerns.
UofU Patient
July 12, 2020
UH HOSPITALS AND CLINICS
Good experience well pleased
UofU Patient
June 19, 2020
UH HOSPITALS AND CLINICS
Seamed to run out of time too quickly. Would have liked to have just a little more time but OK.
UofU Patient
June 10, 2020
EVANSTON REGIONAL HOSPITAL
This was a new experience for me and so appreciate Dr Welt setting me at ease and his help a d kindness.
UofU Patient
June 08, 2020
EVANSTON REGIONAL HOSPITAL
I feel like I need more face to face time
UofU Patient
June 05, 2020
BASIN CLINIC VERNAL
i liked her. very nice but ive had her visit before
UofU Patient
May 11, 2020
EVANSTON REGIONAL HOSPITAL
no personal contact makes for safe, cautious visit
UofU Patient
April 17, 2020
UH HOSPITALS AND CLINICS
good experience if I ever know someone with a heart condition I will tell them about Dr Welt
UofU Patient
February 21, 2020
UH HOSPITALS AND CLINICS
I can see why Dr Welt is recommended by so many people.
UofU Patient
January 21, 2020
UH HOSPITALS AND CLINICS
At the time of my procedure, Dr. Welt offered to call my son, a Navy urologist, to give him all the information about my treatment. I appreciated that. During my first follow-up visit, Dr. Welt asked about my son, and told me to let him know he could call Dr. Welt at any time if my son has questions. Very thoughtful.
Frederick Welt, M.D. is Associate Chief of Cardiovascular Medicine at the University of Utah School of Medicine and Director of the Cardiac Catheterization Laboratory. He is a professor of medicine and member of the Interventional Cardiology faculty.
Dr. Welt most recently served as the Director of Interventional Cardiology at Brigham and Women's Hospital in Boston, as well as Director of the Interventional Cardiovascular Experimental Laboratory. His clinical practice included outpatient clinical care and performing diagnostic catheterizations and coronary interventions.
Dr. Welt specializes in both interventional coronary and structural heart disease cases including Trans Catheter Aortic Valve Replacement (TAVR). His clinical responsibilities include invasive management of acute heart attacks and assessment of valvular heart disease, coronary stent implantation/balloon angioplasty and PFO/ASD closure.
He is also an active clinical investigator, having been involved in the PARTNER trial of transcatheter aortic valve replacement devices, translational research of novel devices to treat structural heart disease and protocols involving stem cell therapy for cardiac disease.
Dr. Welt graduated from the Yale University School of Medicine in 1992, and completed residency and fellowship at the Brigham and Women's Hospital in Boston. He also served as Chief Resident at the West Roxbury VA Hospital and completed a research fellowship at Harvard Medical School. In addition to practicing and teaching at BWH and Harvard he has written numerous journal articles as well as serving as a reviewer for publications.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Professor (Clinical) |
| Academic Divisions | Cardiovascular Medicine |
| Board Certification | American Board of Internal Medicine (Sub: Cardiovascular Disease) American Board of Internal Medicine (Sub: Interventional Cardiology) |
Education History
| Graduate Training | Harvard University Medical Sciences M.S., 2000 |
| Research Fellow | Harvard Medical School, Massachusetts Institute of Technology Clinical Investigator Training Program Research Fellow, 2000 |
| Fellowship | Brigham and Women’s Hospital Interventional Cardiology Fellow, 1998 |
| Fellowship | Brigham and Women’s Hospital Cardiovascular Medicine Clinical Fellow, 1998 |
| Fellowship | South Shore Hospital Cardiology Fellow, 1998 |
| Chief Resident | West Roxbury VA Hospital Internal Medicine Chief Resident, 1995 |
| Residency | Brigham and Women’s Hospital Internal Medicine Senior Assistant Resident, 1995 |
| Residency | Brigham and Women’s Hospital Internal Medicine Junior Assistant Resident, 1994 |
| Professional Medical | Yale University School of Medicine Medicine M.D., 1992 |
| Research Fellow | Pennsylvania State University Earth and Mineral Sciences Research Fellow, 1987 |
| Undergraduate | Duke University Geology B.S., 1985 |
Selected Publications - Journal Articles
Journal Article
- Kleiman NS, Welt FGP, Truesdell AG, Sherwood M, Kadavath S, Shah PB, Klein LW, Hogan S, Kavinsky C, Rab T, Interventional Section Leadership Council American College of Cardiology (2020). Should Interventional Cardiologists Super-Subspecialize?: Moving From Patient Selection to Operator Selection. JACC Cardiovasc Interv, 14(1), 97-100.
- Tandar A, Sharma V, Ibrahim M, Jones T, Morgan D, Montzingo C, Lee J, Birgenheier N, Silverton N, Abraham A, Welt FGP, Glotzbach JP (2021). Preventing or Minimizing Acute Kidney Injury in Patients Undergoing Transcatheter Aortic Valve Replacement. J Invasive Cardiol, 33(1), E32-E39.
- Yong CM, Ang L, Welt FGP, Gummidipundi S, Henry TD, Pinto DS, Cox D, Wang P, Asch S, Mahmud E, Fearon WF, Society for Cardiovascular Angiography and Interventions SCAI and the American College of Cardiology ACC Interventional Council (2020). Cardiac procedural deferral during the coronavirus (COVID-19) pandemic. Catheter Cardiovasc Interv, 96(5), 1080-1086.
- Jones TL, Golomb M, Dranow E, Welt FGP, Shah PB (2020). The case for a qualitative lesion assessment system for coronary angiography. Catheter Cardiovasc Interv.
- Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S (2020). Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: An ACC/SCAI position statement. Catheter Cardiovasc Interv, 96(3), 659-663.
- Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD (2020). Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv, 96(2), 336-345.
- Jones TL, Gowani SA, Abraham A, Sharma V, Glotzbach J, Morgan D, Welt FGP, Tandar A (2020). Trans-septal puncture through Gore® Cardioform Septal Occluder device - Step by step approach. Cardiovasc Revasc Med, 23, 91-93.
- Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW, Young MN, Davidson LJ, Kadavath S, Mahmud E, Kirtane AJ, American College of Cardiologys Interventional Council and the Society for Cardiovascular Angiography and Interventions (2020). Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am Coll Cardiol, 75(18), 2372-2375.
- Tonna JE, McKellar SH, Selzman CH, Drakos S, Koliopoulou AG, Taleb I, Stoddard GJ, Stehlik J, Welt FGP, Fair JF 3rd, Stoddard K, Youngquist ST (2020). Exploratory analysis of myocardial function after extracorporeal cardiopulmonary resuscitation vs conventional cardiopulmonary resuscitation. BMC Res Notes, 13(1), 137.
- Welt FGP, Fang JC (2019). Pressure Volume System for Management of Heart Failure and Valvular Heart Disease. Curr Cardiol Rep, 21(12), 153.
- Fisher JD, Welt FG, Villines TC, Truesdell AG, Young MN, Lakkireddy D, Lee BK, ACCs Electrophysiology Section Leadership Council, ACCs Interventional Section Leadership Council, ACCs Imaging Section Leadership Council (2019). Impact of New Guidelines of Unscheduled and Scheduled Sedation for Cardiologists: JACC Council Perspectives. J Am Coll Cardiol, 74(11), 1505-1511.
- Klein LW, Rab T, Anderson HV, Lotfi A, Truesdell AG, Duffy PL, Welt F, Mehran R, Kleiman NS, Workgroup on Acute Care Cardiology and the Interventional Section Leadership Council, American College of Cardiology (2018). The Implications of Acute Clinical Care Responsibilities on the Contemporary Practice of Interventional Cardiology. JACC Cardiovasc Interv, 12(6), 595-599.
- Sardar P, Enakpene E, Fang JC, Welt FGP (2017). Acute Coronary Syndrome Resulting From Systolic Compression of Left Main Coronary Artery Secondary to Aortic Subvalvular Aneurysm. JACC Cardiovasc Interv, 10(7), e69-e70.
- Sunkara N, Tandar A, Patel AN, Martin MH, Welt FG (2017). Use of a Palmaz Intrahepatic Stent for Fixation of a CoreValve During Treatment of Native Aortic Valve Regurgitation. J Struct Heart Dis, 3(1), 28-34.
- Tandar A, Bull DA, Welt FG (2017). Bioprosthetic Aortic Paravalvular Leak: Is Valve-in-Valve Another Solution? J Invasive Cardiol, 29(1), E1-E7.
- Pasala T, Gajulapalli RD, Bolen S, Bajaj NS, Gandhi S, Tandar A, Owan T, Welt FG (2016). Transradial access mitigates bleeding benefit offered by bivalirudin over heparin in patients undergoing percutaneous coronary intervention: Insights from meta-analysis of randomized and observational studies. Int J Cardiol, 221, 601-8.
- McCabe JM, Huang PH, Cohen DJ, Blackstone EH, Welt FGP, Davidson MJ, Kaneko T, Eng MH, Allen KB, Xu K, Lowry AM, Lei Y, Rajeswaran J, Brown DL, Mack MJ, Webb JG, Smith CR, Leon MB, Eisenhauer AC, PARTNER Trial Investigators (2016). Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). Am J Cardiol, 117(10), 1643-1650.
- Ravindra VM, Mazur MD, Kumpati GS, Park MS, Patel AN, Tandar A, Welt FG, Bull D, Couldwell WT, Taussky P (2016). Carotid Artery Stenosis in the Setting of Transcatheter Aortic Valve Replacement: Clinical and Technical Considerations of Carotid Stenting. World Neurosurg, 86, 194-8.
- Lindley EM, Hall AK, Hess J, Abraham J, Smith B, Hopkins PN, Shihab F, Welt F, Owan T, Fang JC (2016). Cardiovascular Risk Assessment and Management in Prerenal Transplantation Candidates. Am J Cardiol, 117(1), 146-50.
- Rossi JE, Noll A, Bergmark B, McCabe JM, Nemer D, Okada DR, Vasudevan A, Davidson M, Welt F, Eisenhauer A, Shah P, Giugliano R (2015). Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience. Cardiol Ther, 4(2), 197-201.
- Bangalore S, Silbaugh TS, Normand SL, Lovett AF, Welt FG, Resnic FS (2015). Drug-eluting stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv, 85(4), 533-41.
- McCabe JM, Huang PH, Riedl LA, Devireddy SR, Grondell J, Connors AC, Davidson MJ, Eisenhauer AC, Welt FG (2014). Incidence and implications of idiopathic thrombocytopenia following transcatheter aortic valve replacement with the Edwards Sapien((c)) valves: A single center experience. Catheter Cardiovasc Interv, 83(4), 633-41.
- McCabe JM, Joynt KE, Welt FG, Resnic FS (2013). Impact of public reporting and outlier status identification on percutaneous coronary intervention case selection in Massachusetts. JACC Cardiovasc Interv, 6(6), 625-30.
- Welt FG, Gallegos R, Connell J, Kajstura J, DAmario D, Kwong RY, Coelho-Filho O, Shah R, Mitchell R, Leri A, Foley L, Anversa P, Pfeffer MA (2013). Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail, 6(1), 99-106.
- DAmario D, Fiorini C, Campbell PM, Goichberg P, Sanada F, Zheng H, Hosoda T, Rota M, Connell JM, Gallegos RP, Welt FG, Givertz MM, Mitchell RN, Leri A, Kajstura J, Pfeffer MA, Anversa P (2011). Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res, 108(7), 857-61.
- Rybicki FJ, Melchionn S, Mitsouras D, Coskun AU, Whitmore AG, Steigner M, Nallamshetty L, Welt FG, Bernaschi M, Borkin M, Sircar J, Kaxiras E, Succi S, Stone PH, Feldman CL (2009). Prediction of coronary artery plaque progression and potential rupture from 320-detector row prospectively ECG-gated single heart beat CT angiography: Lattice Boltzmann evaluation of endothelial shear stress. Int J Cardiovasc Imaging, 25, 289-99.
- Tahir SM, Price LL, Shah PB, Welt FG (2008). Eighteen year (1985-2002) analysis of incidence, mortality, and cardiac procedure outcomes of acute myocardial infarction in patients > or = 65 years of age. Am J Cardiol, 101(7), 930-6.
- Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, Poh KK, Weinstein R, Kearney M, Chaudhry M, Burg A, Eaton L, Heyd L, Thorne T, Shturman L, Hoffmeister P, Story K, Zak V, Dowling D, Traverse JH, Olson RE, Flanagan J, Sodano D, Murayama T, Kawamoto A, Kusano KF, Wollins J, Welt F, Shah P, Soukas P, Asahara T, Henry TD (2007). Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation, 115(25), 3165-72.
- Welt FG, Rogers SD, Zhang X, Ehlers R, Chen Z, Nannizzi-Alaimo L, Phillips DR, Simon DI (2004). GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention. Catheter Cardiovasc Interv, 61(2), 185-9.
- Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C (2003). Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med, 8(1), 1-7.
- Sedlis SP, Morrison DA, Lorin JD, Esposito R, Sethi G, Sacks J, Henderson W, Grover F, Ramanathan KB, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Murphy E, Ward H, Miller L, Kiesz S, Barbiere C, Lewis D (2002). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol, 40(9), 1555-66.
- Sharma GV, Woods PA, Lambrew CT, Berg CM, Pietro DA, Rocco TP, Welt F, Sacchetti P, McIntyre KM (2002). Evaluation of a noninvasive system for determining left ventricular filling pressure. Arch Intern Med, 162(18), 2084-8.
- Danenberg HD, Welt FG, Walker M 3rd, Seifert P, Toegel GS, Edelman ER (2002). Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation, 105(24), 2917-22.
- Horvath C, Welt FG, Nedelman M, Rao P, Rogers C (2002). Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted. Circ Res, 90(4), 488-94.
- Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan KB, Weiman D, Talley JD, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D (2002). Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol, 39(2), 266-73.
- Welt FG, Woods TC, Edelman ER (2001). Oral heparin prevents neointimal hyperplasia after arterial injury: inhibitory potential depends on type of vascular injury. Circulation, 104(25), 3121-4.
- Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S, Esposito R, Ramanathan K, Weiman D, Saucedo J, Antakli T, Paramesh V, Pett S, Vernon S, Birjiniuk V, Welt F, Krucoff M, Wolfe W, Lucke JC, Mediratta S, Booth D, Barbiere C, Lewis D (2001). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol, 38(1), 143-9.
- Welt FG, Edelman ER, Simon DI, Rogers C (2000). Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries. Arterioscler Thromb Vasc Biol, 20(12), 2553-8.
- Wang SY, Welt FG, Rutlen DL (1998). Severe haemorrhage partially reverses moderate haemorrhage-induced decrease in intestinal vascular capacitance. Acta Physiol Scand, 162(1), 1-8.
- Rogers C, Welt FG, Karnovsky MJ, Edelman ER (1996). Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol, 16(10), 1312-8.
- Rutlen DL, Welt FG, Ilebekk A (1992). Passive effect of reduced cardiac function on splanchnic intravascular volume. Am J Physiol, 262(5 Pt 2), H1361-4.
- Welt FG, Rutlen DL (1991). Effect of vasopressin on systemic capacity. Am J Physiol, 261(5 Pt 2), H1494-8.
- McCaffrey TA, Falcone DJ, Brayton CF, Agarwal LA, Welt FG, Weksler BB (1989). Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol, 109(1), 441-8.
- Eggler DH, Meen JK, Welt F, Dudas FO, Furlong KP, McCallum ME, Carlson RW (1988). Tectonomagmatism of the Wyoming Province. 83, 25-0.
Book Chapter
- Welt FG, Moreno PR (2019). Chapter 1 - Vascular Biology. In Mukherjee D, Lange RA, Chatterjee S, Cho L, Moliterno DJ (Eds.), Interventional Cardiology 1133 Questions: An Interventional Cardiology Board Review (Third Edition, pp. 1-11). Wolters Kluwer.
- Welt FGP, Simon D (2018). Pathobiology of Vascular Disease: Fundamentals of Atherosclerosis. In Moliterno D, Dehmer G, Kandzari D, Rao S, Ziada K (Eds.), CathSap Cardiac Catheterization & Interventional Cardiology Self-Assessment Program (Version 4).
Case Report
Editorial
Letter
Abstract
- Patel J, Fearon W, Elmariah S, Kim J, Kapadia S, Kumbhani D, Gillam L, Whisenant B, Quader N, Welt FG, Maniar H, Bavry A, Zajarias A, Piana R, Melby S, Coylewright M, Vatterott A, Stassi K, Novak E and Lindman B (2017). Depression as a Potential Therapeutic Target to Improve Quality of Life After Transcatheter Aoritc Valve Replacement [Abstract].
Other
- Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD (2020). Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol (76(11), pp. 1375-1384). United States.
- Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, Sherwood M, Batchelor W, Wang DD, Davidson L, Wyman J, Kadavath S, Szerlip M, Hermiller J, Fullerton D, Anwaruddin S, American College of Cardiology and the Society for Cardiovascular Angiography and Interventions (2020). Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement. JACC Cardiovasc Interv (13(12), pp. 1484-1488). United States.